Association between urinary cadmium and all cause, all cancer and prostate cancer specific mortalities for men: An analysis of National Health and Nutrition Examination Survey (NHANES III) data

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 1, 2014, Pages 483-488

  Cheung, Min Rex ^a   Kang, Josephine ^a   Ouyang, Daniel ^a   Yeung, Vincent ^a  

^a FROS Radiation Oncology Cyberknife Center Manhattan Radiation Oncology   (United States)

Author keywords

All cancer survival; All cause survival; Cadmium; NHANES III; Prostate cancer

Indexed keywords

CADMIUM;

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; BODY WEIGHT; CAUSE OF DEATH; ETHNOLOGY; FEMALE; HUMAN; MALE; MEXICAN AMERICAN; MORTALITY; NUTRITION; POVERTY; PROSTATE TUMOR; STATISTICS; URINE;

ADULT; AFRICAN AMERICANS; AGE FACTORS; BODY WEIGHT; CADMIUM; CAUSE OF DEATH; FEMALE; HUMANS; MALE; MEXICAN AMERICANS; NUTRITION SURVEYS; POVERTY; PROSTATIC NEOPLASMS;

EID: 84894040413     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.1.483     Document Type: Article

References (28)

1. Aimola P, Carmignani M, Volpe AR, et al. (2012). Cadmium induces p53-dependent apoptosis in human prostate epithelial cells. PLoS One, 7, e33647.
2. Chang SL, Harshman LC, and Presti JC Jr. (2010). Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and Nutrition Examination Survey. J Clin Oncol, 28, 3951-7.
3. Cheung R. (2012). Poor treatment outcome of neuroblastoma and other peripheral nerve cell tumors may be related to under usage of radiotherapy and socio-economic disparity: A US SEER data analysis. Asian Pac J Cancer Prev, 13, 4587-91.
4. Cohen SB (1997). An evaluation of alternative PC-based packages for the analysis of complex survey data. The American Statistician, 51, 285-92.
5. Cui Y, Winton MI, Zhang ZF, et al. (2004). Dietary boron intake and prostate cancer risk. Oncol Rep, 11, 887-92.
6. Dahiya R, Lee C, Haughney PC, et al (1996). Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines. Urology, 48, 963-70.
7. Ezzati-Rice TM, Murphy RS (1995). Issues associated with the design of a national probability sample for human exposure assessment. Environ Health Perspect, 103 Suppl 3, 55-59.
8. Graubard BI, Korn EL (1999). Analyzing health surveys for cancer-related objectives. J Natl Cancer Inst, 91, 1005-16.
9. Huff J, Lunn RM, Waalkes MP, Tomatis L, and Infante PF. (2007). Cadmium-induced cancers in animals and in humans. Int J Occup Environ Health, 13, 202-2.
10. Jewell NP. (2004). Statistics for Epidemiology, Boca Raton, Florida: Champman & Hall/CRC.
11. Julin B, Wolk A, Johansson JE, et al (2012). Dietary cadmium exposure and prostate cancer incidence: a population-based prospective cohort study. Br J Cancer, 107, 895-900.
12. Lacher DA, Thompson TD, Hughes JP, Saraiya M. (2006). Total, free, and percent free prostate-specific antigen levels among U.S. men, 2001-04. Adv Data, ??, 1-12.
13. Lemeshow S, and Cook ED. (1999). Practical considerations in the analysis of complex sample survey data. Rev Epidemiol Sante Publique, 47, 479-487.
14. Lin YS, Caffrey JL, Lin JW, et al (2013). Increased risk of cancer mortality associated with cadmium exposures in older americans with low zinc intake. J Toxicol Environ Health, A 76, 1-15.
15. Menke A, Guallar E, Rohrmann S, et al (2010). Sex steroid hormone concentrations and risk of death in US men. Am J Epidemiol, 171, 583-592.
16. Mondul AM, Rohrmann S, Menke A, et al. (2011). Association of serum alpha-tocopherol with sex steroid hormones and interactions with smoking: implications for prostate cancer risk. Cancer Causes Control, 22, 827-836.
17. Mondul AM, Selvin E, Rohrmann S, et al (2010). Association of serum cholesterol and cholesterol-lowering drug use with serum sex steroid hormones in men in NHANES III. Cancer Causes Control, 21, 1575-83.
18. Parekh N, Lin Y, Dipaola RS, Marcella S, Lu-Yao G (2010). Obesity and prostate cancer detection: insights from three national surveys. Am J Med, 123, 829-35.
19. Rohrmann S, Giovannucci E, Smit E, Platz EA (2007a). Association of IGF-1 and IGFBP-3 with lower urinary tract symptoms in the third National Health and Nutrition Examination Survey. Prostate, 67, 1693-8.
20. Rohrmann S, Nelson WG, Rifai N, et al (2007b). Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans. J Clin Endocrinol Metab, 92, 2519-25.
21. Rothman KJ, Greenland S, Lash TL (2008). Modern Epidemiology, 3rd edn (Philadelphia, Pennsylvania: Lippincott Williams & Wilkins).
22. Satarug S (2012). Long-term exposure to cadmium in food and cigarette smoke, liver effects and hepatocellular carcinoma. Curr Drug Metab, 13, 257-71.
23. Shand RL, Gelmann EP. (2006). Molecular biology of prostate-cancer pathogenesis. Curr Opin Urology, 16, 123-31.
24. Shiels MS, Rohrmann S, Menke A, et al (2009). Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men. Cancer Causes Control, 20, 877-86.
25. Siegel R, Desantis C, Virgo K, et al (2012). Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin, 62, 220-41.
26. Strom SS, Kamat AM, Gruschkus SK, et al. (2006). Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer, 107, 631-9.
27. Tseng M, Breslow RA, Graubard BI, Ziegler RG (2005). Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort. Am J Clin Nutr, 81, 1147-54.
28. van Wijngaarden E, Singer EA, and Palapattu GS. (2008). Prostate-specific antigen levels in relation to cadmium exposure and zinc intake: results from the 2001-2002 National Health and Nutrition Examination Survey. Prostate, 68, 122-8.